Alzheimer's Animal Model
•Download as PPTX, PDF•
1 like•2,865 views
BRM has developed proprietary rat strains which are translatable models for the characterization of type 1 and type 2 diabetes as well as immune-related diseases. Its technical competencies include design and conducting studies in autoimmunity (type 1 diabetes, lupus, Rheumatoid Arthritis and Multiple Sclerosis), metabolic disease (type 2 diabetes, metabolic syndrome, obesity, dyslipidemia, liver and kidney function), virology, neurodegenerative diseases, diabetic complications (retinopathy, neuropathy, nephropathy, and encephalopathy including Alzheimer’s disease) specialized animal model development and the production and care of multiple species.
Report
Share
Report
Share
Recommended
Antipsychotic screening- Dr Divya Krishnan
This document summarizes a seminar on screening methods for antipsychotic drugs. It discusses various animal models used to screen antipsychotics, including pharmacological models using dopamine agonists like amphetamine that cause hyperactivity and stereotypy in rats, and glutamatergic models using NMDA antagonists like phencyclidine. Commonly used tests involve measuring a drug's ability to inhibit amphetamine-induced hyperactivity and stereotypy in rats, which can identify drugs with D2 receptor blocking effects. Newer models based on deficits in sensory gating like prepulse inhibition of the startle response are also described. No animal model fully captures the human condition of schizophrenia, but these tests provide methods to screen drugs' antip
Screening of Drugs acting on ANS
This document describes methods for testing and characterizing drugs that act on the sympathetic or parasympathetic nervous systems. It provides details on techniques using isolated tissues and whole animals to study effects of potential sympathomimetic, sympatholytic, parasympathomimetic, and parasympatholytic drugs. These include measuring changes in pupil diameter, tracheal smooth muscle contraction, rat uterus response, and blood pressure as indicators of sympathetic or parasympathetic activity.
General principle of preclinical screening
Preclinical screening involves testing new drugs or chemicals on animal subjects before human testing to determine if they are safe and effective. There are three main types of screening: simple screening uses one or two tests to find substances with a particular property; blind screening is for new chemicals without prior history to identify fields of activity and most potent compounds; programmed screening provides information on what activities different compounds have through a series of organ- or system-specific tests. Screening methods include in vitro experiments using isolated tissues, cell cultures, and chemical assays as well as ex vivo and in vivo animal experiments and in silico computer modeling.
Screening of antihypertensive agents
This document describes various in vivo and in vitro models used to study antihypertensive and vasodilator drugs. In vivo models include the Goldblatt hypertension model in rats, chronic renal hypertension in rats and dogs, and the tail cuff method in rats. In vitro models include ACE inhibition in guinea pig ileum and β1 sympatholytic activity in guinea pig atria. The document also provides details of the procedures for these models.
Screening of Diuretics M.PHARM PHARMACOLOGY.
This document discusses various in vitro and in vivo models for screening diuretic agents. It describes the Lipschitz test for evaluating diuretic activity in rats by measuring urine excretion and sodium content compared to a urea control. It also discusses methods to evaluate saluretic activity in rats by analyzing urine electrolytes and ratios. Clearance methods to assess renal function and site of action are described using conscious dogs under water diuresis and hydropenia conditions. The stop flow technique is explained to study transport along the nephron by clamping the ureter and collecting sequential urine samples.
Alzheimer models
The document summarizes screening models for Alzheimer's disease. It describes two in vitro methods - inhibition of acetylcholine-esterase activity in rat striatum and inhibition of butyrylcholine-esterase activity in human serum. It also describes two in vivo methods - the step-down test and scopolamine-induced amnesia in mice. The step-down test measures learning and memory in rats using an elevated platform and electric shock. The scopolamine-induced amnesia test measures the ability of drugs to reverse memory deficits caused by the antimuscarinic scopolamine in mice. The document provides details on the procedures and evaluations of these screening methods.
Screening Methods of Parkinson's Disease
Screening Methods of Parkinson's Disease
Submitted To - Dr. Saumya Das,Asst.Professor
NIET(Pharmacy Institute)
Submitted By- Neeraj Rana
NIET(Pharmacy Institute)
Screening of anti anxiety drugs
The document discusses various screening methods for evaluating potential anxiolytic drugs, including in vitro receptor binding assays and in vivo behavioral tests in animals like the elevated plus maze test, light-dark box test, and social interaction test, which measure anxiety-like behaviors that can be reduced by anxiolytic drug administration. Classification of anxiolytics and theories of anxiety involving neurotransmitters like GABA, serotonin and norepinephrine are also covered.
Recommended
Antipsychotic screening- Dr Divya Krishnan
This document summarizes a seminar on screening methods for antipsychotic drugs. It discusses various animal models used to screen antipsychotics, including pharmacological models using dopamine agonists like amphetamine that cause hyperactivity and stereotypy in rats, and glutamatergic models using NMDA antagonists like phencyclidine. Commonly used tests involve measuring a drug's ability to inhibit amphetamine-induced hyperactivity and stereotypy in rats, which can identify drugs with D2 receptor blocking effects. Newer models based on deficits in sensory gating like prepulse inhibition of the startle response are also described. No animal model fully captures the human condition of schizophrenia, but these tests provide methods to screen drugs' antip
Screening of Drugs acting on ANS
This document describes methods for testing and characterizing drugs that act on the sympathetic or parasympathetic nervous systems. It provides details on techniques using isolated tissues and whole animals to study effects of potential sympathomimetic, sympatholytic, parasympathomimetic, and parasympatholytic drugs. These include measuring changes in pupil diameter, tracheal smooth muscle contraction, rat uterus response, and blood pressure as indicators of sympathetic or parasympathetic activity.
General principle of preclinical screening
Preclinical screening involves testing new drugs or chemicals on animal subjects before human testing to determine if they are safe and effective. There are three main types of screening: simple screening uses one or two tests to find substances with a particular property; blind screening is for new chemicals without prior history to identify fields of activity and most potent compounds; programmed screening provides information on what activities different compounds have through a series of organ- or system-specific tests. Screening methods include in vitro experiments using isolated tissues, cell cultures, and chemical assays as well as ex vivo and in vivo animal experiments and in silico computer modeling.
Screening of antihypertensive agents
This document describes various in vivo and in vitro models used to study antihypertensive and vasodilator drugs. In vivo models include the Goldblatt hypertension model in rats, chronic renal hypertension in rats and dogs, and the tail cuff method in rats. In vitro models include ACE inhibition in guinea pig ileum and β1 sympatholytic activity in guinea pig atria. The document also provides details of the procedures for these models.
Screening of Diuretics M.PHARM PHARMACOLOGY.
This document discusses various in vitro and in vivo models for screening diuretic agents. It describes the Lipschitz test for evaluating diuretic activity in rats by measuring urine excretion and sodium content compared to a urea control. It also discusses methods to evaluate saluretic activity in rats by analyzing urine electrolytes and ratios. Clearance methods to assess renal function and site of action are described using conscious dogs under water diuresis and hydropenia conditions. The stop flow technique is explained to study transport along the nephron by clamping the ureter and collecting sequential urine samples.
Alzheimer models
The document summarizes screening models for Alzheimer's disease. It describes two in vitro methods - inhibition of acetylcholine-esterase activity in rat striatum and inhibition of butyrylcholine-esterase activity in human serum. It also describes two in vivo methods - the step-down test and scopolamine-induced amnesia in mice. The step-down test measures learning and memory in rats using an elevated platform and electric shock. The scopolamine-induced amnesia test measures the ability of drugs to reverse memory deficits caused by the antimuscarinic scopolamine in mice. The document provides details on the procedures and evaluations of these screening methods.
Screening Methods of Parkinson's Disease
Screening Methods of Parkinson's Disease
Submitted To - Dr. Saumya Das,Asst.Professor
NIET(Pharmacy Institute)
Submitted By- Neeraj Rana
NIET(Pharmacy Institute)
Screening of anti anxiety drugs
The document discusses various screening methods for evaluating potential anxiolytic drugs, including in vitro receptor binding assays and in vivo behavioral tests in animals like the elevated plus maze test, light-dark box test, and social interaction test, which measure anxiety-like behaviors that can be reduced by anxiolytic drug administration. Classification of anxiolytics and theories of anxiety involving neurotransmitters like GABA, serotonin and norepinephrine are also covered.
Screening Models of Anti-Inflammatory Drugs
Screening Models of Anti-Inflammatory Drugs
Submitted To - Dr. Saumya Das,Asst. Professor
NIET(Pharmacy Institute),Greater Noida
Submitted By - Ayush Atri, M.Pharm,Pharmacology (1st Sem.)
NIET(Pharmacy Institute),Greater Noida
Drug screening methods for antiarrhythmic agents
This document describes various in vitro and in vivo drug screening methods for evaluating potential antiarrhythmic agents. In vitro methods include using acetylcholine or potassium to induce arrhythmias in isolated rabbit atria and the Langendorff technique of perfusing isolated guinea pig hearts. In vivo methods involve chemically inducing arrhythmias using drugs like aconitine, digoxin, strophanthin, and adrenaline in rats and dogs. Other methods include electrically inducing arrhythmias by determining ventricular fibrillation threshold and using programmed stimulation in dogs with induced myocardial ischemia. A canine model of sudden coronary death is also described.
Screening method of nootropics vikas malik
1. The document describes various methods for screening nootropic substances, including in vivo, in vitro, and molecular-level experiments.
2. Some key in vivo methods discussed are passive avoidance testing in rats/mice, active avoidance conditioning experiments, and electrophysiological studies like long-term potentiation experiments in hippocampal brain slices.
3. In vitro screening methods outlined involve measuring inhibition of acetylcholinesterase activity from rat brain tissue and butyrylcholinesterase activity from human serum. Molecular-level experiments involve analyzing effects on acetylcholine receptors and neurotransmitter release.
screening model for learning and memory
This document summarizes several memory screening models used in animal studies. It describes the passive avoidance test which assesses memory by measuring how long a mouse stands on an elevated platform to avoid a foot shock. It also describes the step-through test and scopolamine-induced amnesia model in mice. Spatial memory tests are discussed, including the radial arm maze and Morris water maze. Two studies are summarized, one on hesperidin and silibinin ameliorating aluminum-induced memory deficits, and another on amyloid-β1–42 oligomers inducing memory deficits.
Screening of Antihyperlipidemic drugs
Includes in vivo and in vitro models for the screening of antihyperlipidemic drugs. Types of lipoproteins, their structures and functions.
Screening methods of anti hypertensive agents
This document discusses screening methods for antihypertensive agents. It begins with an introduction on hypertension and its prevalence. It then discusses various animal models used to study hypertension including spontaneous hypertensive rats. It provides details on several in vivo and in vitro screening models for inducing and studying hypertension including acute renal hypertension in rats, chronic renal hypertension in rats and dogs, and genetic hypertension in rats. It describes procedures, evaluations, and modifications of these methods. The goal is to utilize animal models that replicate features of human hypertension to screen for new antihypertensive agents.
Screening of antipyretic drugs
This document summarizes screening methods for evaluating the antipyretic (fever-reducing) effects of drugs in animal models. It describes using the Brewer's yeast suspension method to induce fever in rats and rabbits, and then testing potential antipyretic drugs. Key points:
1) Drugs are given to fevered animals and temperatures recorded at intervals to see if drugs lower elevated body temperatures compared to controls.
2) Studies summarized evaluated antipyretic effects of extracts from Bauhinia racemosa and Gracilaria corticata seaweed in rats. Both produced significant antipyretic activity.
3) The rabbit model uses bacterial lipopolysaccharides to induce fever and tests
Screening of Anxiolytics
This document summarizes several preclinical models used to screen anxiolytic agents. It describes anxiety disorders and the goal of developing animal models that resemble human pathology. Several models are explained in detail, including the elevated plus maze test, light-dark exploration test, and social interaction test in rats. These tests measure anxiety-like behaviors in rodents and can determine if candidate drugs decrease inhibited behaviors. The document also reviews in vitro and in vivo methods for evaluating putative anxiolytics before clinical trials.
Screening models for aphrodisiac agents and anti fertility agents
This document discusses guidelines for conducting studies on aphrodisiac and anti-fertility agents in animals. It outlines various in vivo and in vitro screening models used to test the effects of these drugs, including mating behavior tests, libido tests, assessment of sperm parameters, and estimation of sex hormone levels. The guidelines specify how to properly house and train male and female animals, and evaluate behaviors like mounting frequency, intromission latency, and ejaculation. Common aphrodisiac drugs discussed include sildenafil, arginine, and testosterone, while benefits and screening of anti-fertility agents are also summarized.
Screening models for inflammatory drugs
This document summarizes screening methods for evaluating potential anti-inflammatory drugs. It discusses the inflammatory response and various animal models used to test drug candidates, including carrageenan-induced paw edema, cotton pellet-induced granuloma, and UVB-induced erythema in guinea pigs. Several in vitro assays are also described, such as measuring COX inhibition and evaluating the ability of drugs to block mast cell degranulation and platelet-neutrophil adhesion. The goal of these screening methods is to effectively identify drug candidates that can target different phases and components of the inflammatory process.
Animal Models for Seizure and Epilepsy
Explanation of Preclinical (Animal) Models of Seizure and Epilepsy.
General overview of Seizure and Epilepsy and its current Management. Need to develop newer drugs and Newer models. Current models for Acute Seizure. Kindling explained. PPT contains overview and Protocol.
Evaluation methods of anti-asthmatics
This document discusses various methods for evaluating anti-asthmatic drugs, including both in vitro and in vivo methods. It provides details on common animal models and techniques used. Some key points:
- Asthma is a global health problem affecting 7-10% of the world's population. It is characterized by airway inflammation, obstruction, and hyperresponsiveness.
- Both acute toxicity tests in mice and various assays evaluating effects on isolated organs, cells, and receptors are used to initially screen potential anti-asthmatic drugs in vitro.
- Popular in vivo models include measuring bronchospasm in guinea pigs and studying effects on histamine-induced bronchoconstriction, arachidonic acid responses,
Screening Models Of Anti Cancer Drugs
Screening Models Of Anti Cancer DrugsRaghavendra institute of pharmaceutical education and research .
Introduction to Screening Models Of Anti Cancer Drugs
Need for novel anti cancer drugs, In - vitro methods, In - vivo methods, Advantages and disadvantages
Presented by
T. Niranjan Reddy
Department of Pharmacology Preclinical screening of antiallergics
The document describes several in vitro and in vivo methods used to study anti-allergic and anti-inflammatory drugs. In vitro methods include inhibition of histamine release from mast cells and inhibition of T cell proliferation. In vivo methods include a rat anaphylaxis model, guinea pig Schultz-Dale reaction, and passive cutaneous anaphylaxis in rats. One method involves sensitizing rats with ovalbumin, then challenging them to induce shock, which can be counteracted by test drugs. Another involves sensitizing guinea pigs to egg albumin to study contractions in response to ovalbumin.
Screening of antiparkinson agent
This document summarizes screening methods for potential antiparkinson agents. It describes several in vivo and in vitro models used to test compounds. The key in vivo models discussed are:
1. Tremorine and oxotremorine antagonism in mice, which tests a compound's ability to reduce tremors induced by these muscarinic agonists.
2. The MPTP model in monkeys and mice, which uses MPTP to damage dopaminergic neurons and induce Parkinson's-like symptoms that can be reversed or reduced by test compounds.
3. Reserpine antagonism in rats, which tests if a compound can reduce sedation and motor impairment caused by reserpine depletion of cate
Screening of antiparkinsonian agents
This document describes various in vivo and in vitro models used for screening potential antiparkinsonian drugs. Some key in vivo models mentioned include: 1) antagonism of tremors induced by tremorine/oxotremorine in mice, 2) use of the MPTP model in monkeys to induce Parkinson's disease-like symptoms, and 3) antagonism of sedation induced by reserpine in mice. Important in vitro/ex vivo models include measuring dopamine-stimulated adenylyl cyclase activity and radioligand binding studies for dopamine receptors. The document provides details on the procedures, evaluations, and modifications of these various screening models.
General principles of preclinical screening
Introduction of
GENERAL PRINCIPLES OF PRECLINICAL SCREENING, Types of Screening, Preclinical Studies and its methods,
screening methods for Antiepileptic activity
This document summarizes various preclinical screening methods used to evaluate potential anti-epileptic drugs. It describes several animal models of induced seizures including electroshock seizures, chemical-induced seizures using pentylenetetrazol or picrotoxin. It also discusses genetic models like the totterer mouse that is prone to spontaneous seizures. The key methods are maximal electroshock in mice/rats to test generalized tonic-clonic seizure protection and the pentylenetetrazol test in mice to assess anticonvulsant effects against petit mal-like seizures. These preclinical tests aim to predict potential efficacy of new compounds before clinical trials in humans.
screening methodes of anti-diabetic drugs
Diabetes mellitus is chronic metabolic disease , occurs when the pancreas is not producing insulin or produced insulin cannot be used by the body, or combination of both.
In-Vivo & In-Vitro screening of Anti-asthmatic Drug
In-Vivo & In-Vitro screening of Anti-asthmatic Drug
BIPLOB DEY
Shri Guru Ram Rai University,Dehradun
A Model of Type 2 Diabetes: BBZDR/Wor rat
BRM is a successful biopharmaceutical company formed in 1996 by Dennis Guberski and Dr. Arthur Like of the University of Massachusetts Medical School (UMass). Over the course of 20 years the founders developed proprietary diabetes research models under the sponsorship of the National Institute of Diabetes, Digestive and Kidney Diseases (NIDDK). BRM licensed this intellectual property portfolio from UMass in 1998 and since that time has used these proprietary tools to become one of the leading sources of customized preclinical contract research specializing in type 1 and type 2 diabetes.
Type 1 Diabetes Pre-Clinical Research
BRM is a successful biopharmaceutical company formed in 1996 by Dennis Guberski and Dr. Arthur Like of the University of Massachusetts Medical School (UMass). Over the course of 20 years the founders developed proprietary diabetes research models under the sponsorship of the National Institute of Diabetes, Digestive and Kidney Diseases (NIDDK). BRM licensed this intellectual property portfolio from UMass in 1998 and since that time has used these proprietary tools to become one of the leading sources of customized preclinical contract research specializing in type 1 and type 2 diabetes.
More Related Content
What's hot
Screening Models of Anti-Inflammatory Drugs
Screening Models of Anti-Inflammatory Drugs
Submitted To - Dr. Saumya Das,Asst. Professor
NIET(Pharmacy Institute),Greater Noida
Submitted By - Ayush Atri, M.Pharm,Pharmacology (1st Sem.)
NIET(Pharmacy Institute),Greater Noida
Drug screening methods for antiarrhythmic agents
This document describes various in vitro and in vivo drug screening methods for evaluating potential antiarrhythmic agents. In vitro methods include using acetylcholine or potassium to induce arrhythmias in isolated rabbit atria and the Langendorff technique of perfusing isolated guinea pig hearts. In vivo methods involve chemically inducing arrhythmias using drugs like aconitine, digoxin, strophanthin, and adrenaline in rats and dogs. Other methods include electrically inducing arrhythmias by determining ventricular fibrillation threshold and using programmed stimulation in dogs with induced myocardial ischemia. A canine model of sudden coronary death is also described.
Screening method of nootropics vikas malik
1. The document describes various methods for screening nootropic substances, including in vivo, in vitro, and molecular-level experiments.
2. Some key in vivo methods discussed are passive avoidance testing in rats/mice, active avoidance conditioning experiments, and electrophysiological studies like long-term potentiation experiments in hippocampal brain slices.
3. In vitro screening methods outlined involve measuring inhibition of acetylcholinesterase activity from rat brain tissue and butyrylcholinesterase activity from human serum. Molecular-level experiments involve analyzing effects on acetylcholine receptors and neurotransmitter release.
screening model for learning and memory
This document summarizes several memory screening models used in animal studies. It describes the passive avoidance test which assesses memory by measuring how long a mouse stands on an elevated platform to avoid a foot shock. It also describes the step-through test and scopolamine-induced amnesia model in mice. Spatial memory tests are discussed, including the radial arm maze and Morris water maze. Two studies are summarized, one on hesperidin and silibinin ameliorating aluminum-induced memory deficits, and another on amyloid-β1–42 oligomers inducing memory deficits.
Screening of Antihyperlipidemic drugs
Includes in vivo and in vitro models for the screening of antihyperlipidemic drugs. Types of lipoproteins, their structures and functions.
Screening methods of anti hypertensive agents
This document discusses screening methods for antihypertensive agents. It begins with an introduction on hypertension and its prevalence. It then discusses various animal models used to study hypertension including spontaneous hypertensive rats. It provides details on several in vivo and in vitro screening models for inducing and studying hypertension including acute renal hypertension in rats, chronic renal hypertension in rats and dogs, and genetic hypertension in rats. It describes procedures, evaluations, and modifications of these methods. The goal is to utilize animal models that replicate features of human hypertension to screen for new antihypertensive agents.
Screening of antipyretic drugs
This document summarizes screening methods for evaluating the antipyretic (fever-reducing) effects of drugs in animal models. It describes using the Brewer's yeast suspension method to induce fever in rats and rabbits, and then testing potential antipyretic drugs. Key points:
1) Drugs are given to fevered animals and temperatures recorded at intervals to see if drugs lower elevated body temperatures compared to controls.
2) Studies summarized evaluated antipyretic effects of extracts from Bauhinia racemosa and Gracilaria corticata seaweed in rats. Both produced significant antipyretic activity.
3) The rabbit model uses bacterial lipopolysaccharides to induce fever and tests
Screening of Anxiolytics
This document summarizes several preclinical models used to screen anxiolytic agents. It describes anxiety disorders and the goal of developing animal models that resemble human pathology. Several models are explained in detail, including the elevated plus maze test, light-dark exploration test, and social interaction test in rats. These tests measure anxiety-like behaviors in rodents and can determine if candidate drugs decrease inhibited behaviors. The document also reviews in vitro and in vivo methods for evaluating putative anxiolytics before clinical trials.
Screening models for aphrodisiac agents and anti fertility agents
This document discusses guidelines for conducting studies on aphrodisiac and anti-fertility agents in animals. It outlines various in vivo and in vitro screening models used to test the effects of these drugs, including mating behavior tests, libido tests, assessment of sperm parameters, and estimation of sex hormone levels. The guidelines specify how to properly house and train male and female animals, and evaluate behaviors like mounting frequency, intromission latency, and ejaculation. Common aphrodisiac drugs discussed include sildenafil, arginine, and testosterone, while benefits and screening of anti-fertility agents are also summarized.
Screening models for inflammatory drugs
This document summarizes screening methods for evaluating potential anti-inflammatory drugs. It discusses the inflammatory response and various animal models used to test drug candidates, including carrageenan-induced paw edema, cotton pellet-induced granuloma, and UVB-induced erythema in guinea pigs. Several in vitro assays are also described, such as measuring COX inhibition and evaluating the ability of drugs to block mast cell degranulation and platelet-neutrophil adhesion. The goal of these screening methods is to effectively identify drug candidates that can target different phases and components of the inflammatory process.
Animal Models for Seizure and Epilepsy
Explanation of Preclinical (Animal) Models of Seizure and Epilepsy.
General overview of Seizure and Epilepsy and its current Management. Need to develop newer drugs and Newer models. Current models for Acute Seizure. Kindling explained. PPT contains overview and Protocol.
Evaluation methods of anti-asthmatics
This document discusses various methods for evaluating anti-asthmatic drugs, including both in vitro and in vivo methods. It provides details on common animal models and techniques used. Some key points:
- Asthma is a global health problem affecting 7-10% of the world's population. It is characterized by airway inflammation, obstruction, and hyperresponsiveness.
- Both acute toxicity tests in mice and various assays evaluating effects on isolated organs, cells, and receptors are used to initially screen potential anti-asthmatic drugs in vitro.
- Popular in vivo models include measuring bronchospasm in guinea pigs and studying effects on histamine-induced bronchoconstriction, arachidonic acid responses,
Screening Models Of Anti Cancer Drugs
Screening Models Of Anti Cancer DrugsRaghavendra institute of pharmaceutical education and research .
Introduction to Screening Models Of Anti Cancer Drugs
Need for novel anti cancer drugs, In - vitro methods, In - vivo methods, Advantages and disadvantages
Presented by
T. Niranjan Reddy
Department of Pharmacology Preclinical screening of antiallergics
The document describes several in vitro and in vivo methods used to study anti-allergic and anti-inflammatory drugs. In vitro methods include inhibition of histamine release from mast cells and inhibition of T cell proliferation. In vivo methods include a rat anaphylaxis model, guinea pig Schultz-Dale reaction, and passive cutaneous anaphylaxis in rats. One method involves sensitizing rats with ovalbumin, then challenging them to induce shock, which can be counteracted by test drugs. Another involves sensitizing guinea pigs to egg albumin to study contractions in response to ovalbumin.
Screening of antiparkinson agent
This document summarizes screening methods for potential antiparkinson agents. It describes several in vivo and in vitro models used to test compounds. The key in vivo models discussed are:
1. Tremorine and oxotremorine antagonism in mice, which tests a compound's ability to reduce tremors induced by these muscarinic agonists.
2. The MPTP model in monkeys and mice, which uses MPTP to damage dopaminergic neurons and induce Parkinson's-like symptoms that can be reversed or reduced by test compounds.
3. Reserpine antagonism in rats, which tests if a compound can reduce sedation and motor impairment caused by reserpine depletion of cate
Screening of antiparkinsonian agents
This document describes various in vivo and in vitro models used for screening potential antiparkinsonian drugs. Some key in vivo models mentioned include: 1) antagonism of tremors induced by tremorine/oxotremorine in mice, 2) use of the MPTP model in monkeys to induce Parkinson's disease-like symptoms, and 3) antagonism of sedation induced by reserpine in mice. Important in vitro/ex vivo models include measuring dopamine-stimulated adenylyl cyclase activity and radioligand binding studies for dopamine receptors. The document provides details on the procedures, evaluations, and modifications of these various screening models.
General principles of preclinical screening
Introduction of
GENERAL PRINCIPLES OF PRECLINICAL SCREENING, Types of Screening, Preclinical Studies and its methods,
screening methods for Antiepileptic activity
This document summarizes various preclinical screening methods used to evaluate potential anti-epileptic drugs. It describes several animal models of induced seizures including electroshock seizures, chemical-induced seizures using pentylenetetrazol or picrotoxin. It also discusses genetic models like the totterer mouse that is prone to spontaneous seizures. The key methods are maximal electroshock in mice/rats to test generalized tonic-clonic seizure protection and the pentylenetetrazol test in mice to assess anticonvulsant effects against petit mal-like seizures. These preclinical tests aim to predict potential efficacy of new compounds before clinical trials in humans.
screening methodes of anti-diabetic drugs
Diabetes mellitus is chronic metabolic disease , occurs when the pancreas is not producing insulin or produced insulin cannot be used by the body, or combination of both.
In-Vivo & In-Vitro screening of Anti-asthmatic Drug
In-Vivo & In-Vitro screening of Anti-asthmatic Drug
BIPLOB DEY
Shri Guru Ram Rai University,Dehradun
What's hot (20)
Screening models for aphrodisiac agents and anti fertility agents
Screening models for aphrodisiac agents and anti fertility agents
In-Vivo & In-Vitro screening of Anti-asthmatic Drug
In-Vivo & In-Vitro screening of Anti-asthmatic Drug
More from Biomedical Research Models, Inc.
A Model of Type 2 Diabetes: BBZDR/Wor rat
BRM is a successful biopharmaceutical company formed in 1996 by Dennis Guberski and Dr. Arthur Like of the University of Massachusetts Medical School (UMass). Over the course of 20 years the founders developed proprietary diabetes research models under the sponsorship of the National Institute of Diabetes, Digestive and Kidney Diseases (NIDDK). BRM licensed this intellectual property portfolio from UMass in 1998 and since that time has used these proprietary tools to become one of the leading sources of customized preclinical contract research specializing in type 1 and type 2 diabetes.
Type 1 Diabetes Pre-Clinical Research
BRM is a successful biopharmaceutical company formed in 1996 by Dennis Guberski and Dr. Arthur Like of the University of Massachusetts Medical School (UMass). Over the course of 20 years the founders developed proprietary diabetes research models under the sponsorship of the National Institute of Diabetes, Digestive and Kidney Diseases (NIDDK). BRM licensed this intellectual property portfolio from UMass in 1998 and since that time has used these proprietary tools to become one of the leading sources of customized preclinical contract research specializing in type 1 and type 2 diabetes.
POSTER: Characterization studies of the mad rat: Rheumatoid Arthritis
POSTER: Characterization studies of the mad rat: Rheumatoid ArthritisBiomedical Research Models, Inc.
- The MAD rat strain was developed to be susceptible to multiple autoimmune diseases. This study characterized the susceptibility of MAD rats to adjuvant-induced arthritis (AIA), a model of rheumatoid arthritis.
- MAD rats were found to be highly sensitive to developing inflammatory arthritis after AIA induction. Symptoms progressed from small to large joints similarly to human rheumatoid arthritis.
- A novel finding was the appearance of skin nodules coinciding with arthritis, resembling early rheumatoid nodules in humans. Treatment with dexamethasone inhibited arthritis while methotrexate partially inhibited it.POSTER: Characterization studies of the mad rat: Type 1 Diabetes
1. Biomedical Research Models, Inc. developed an inbred rat strain called the Multiple Autoimmune Disease (MAD) rat that is susceptible to developing multiple autoimmune diseases. This study characterized the MAD rat model of type 1 diabetes (T1D).
2. The study found that Toll-like receptor (TLR) ligands like polyinosinic-polycytidylic acid (poly I:C) could reliably induce T1D in MAD rats, while the TLR ligand CpG did not induce diabetes. Poly I:C induced T1D in a dose-dependent manner.
3. T1D could be induced in MAD rats up to 34 days of age but the penetrance diminished at
BRM Virology, Viral Immunology and Pathology
BRM's Capabilities in Virology, Viral Immunology and Pathology: HSV-1, HSV-2, Influenza, RSV, LCMV, and CMV. For more information, please visit our website at www.BRMCRO.com.
BRM Experimental Autoimmune Encephalomyelitis Models
"The LEW.1WR1 rat is the only model so far that exhibits a low incidence of spontaneous diabetes that can be increased by perturbation. By far the most extensively studied of the models are the two BB rat strains, but all of them have provided interesting information. There are to date no rat models based on the insertion of transgenes, though genetic complementation has been used elegantly to identify the genetic defect in Komeda rats."
BRM's Validated Lupus Model
BRM has experience developing preclinical models for systemic lupus erythematosus (SLE) including the NZB/W F1 and MRL/lpr mouse models. These mice develop anti-dsDNA antibodies and progressive glomerulonephritis similar to human SLE. BRM has validated methods for measuring disease outcomes like proteinuria, antibody levels, immune cell profiles, and histopathology in these mice. They have also demonstrated prevention and remission of lupus symptoms in NZB/W F1 mice using treatments like anti-CD40L monoclonal antibody.
More from Biomedical Research Models, Inc. (7)
POSTER: Characterization studies of the mad rat: Rheumatoid Arthritis
POSTER: Characterization studies of the mad rat: Rheumatoid Arthritis
POSTER: Characterization studies of the mad rat: Type 1 Diabetes
POSTER: Characterization studies of the mad rat: Type 1 Diabetes
BRM Experimental Autoimmune Encephalomyelitis Models
BRM Experimental Autoimmune Encephalomyelitis Models
Recently uploaded
MICROBIAL INTERACTION PPT/ MICROBIAL INTERACTION AND THEIR TYPES // PLANT MIC...
MICROBIAL INTERACTION PPT/ MICROBIAL INTERACTION AND THEIR TYPES // PLANT MIC...ABHISHEK SONI NIMT INSTITUTE OF MEDICAL AND PARAMEDCIAL SCIENCES , GOVT PG COLLEGE NOIDA
Microbial interaction
Microorganisms interacts with each other and can be physically associated with another organisms in a variety of ways.
One organism can be located on the surface of another organism as an ectobiont or located within another organism as endobiont.
Microbial interaction may be positive such as mutualism, proto-cooperation, commensalism or may be negative such as parasitism, predation or competition
Types of microbial interaction
Positive interaction: mutualism, proto-cooperation, commensalism
Negative interaction: Ammensalism (antagonism), parasitism, predation, competition
I. Mutualism:
It is defined as the relationship in which each organism in interaction gets benefits from association. It is an obligatory relationship in which mutualist and host are metabolically dependent on each other.
Mutualistic relationship is very specific where one member of association cannot be replaced by another species.
Mutualism require close physical contact between interacting organisms.
Relationship of mutualism allows organisms to exist in habitat that could not occupied by either species alone.
Mutualistic relationship between organisms allows them to act as a single organism.
Examples of mutualism:
i. Lichens:
Lichens are excellent example of mutualism.
They are the association of specific fungi and certain genus of algae. In lichen, fungal partner is called mycobiont and algal partner is called
II. Syntrophism:
It is an association in which the growth of one organism either depends on or improved by the substrate provided by another organism.
In syntrophism both organism in association gets benefits.
Compound A
Utilized by population 1
Compound B
Utilized by population 2
Compound C
utilized by both Population 1+2
Products
In this theoretical example of syntrophism, population 1 is able to utilize and metabolize compound A, forming compound B but cannot metabolize beyond compound B without co-operation of population 2. Population 2is unable to utilize compound A but it can metabolize compound B forming compound C. Then both population 1 and 2 are able to carry out metabolic reaction which leads to formation of end product that neither population could produce alone.
Examples of syntrophism:
i. Methanogenic ecosystem in sludge digester
Methane produced by methanogenic bacteria depends upon interspecies hydrogen transfer by other fermentative bacteria.
Anaerobic fermentative bacteria generate CO2 and H2 utilizing carbohydrates which is then utilized by methanogenic bacteria (Methanobacter) to produce methane.
ii. Lactobacillus arobinosus and Enterococcus faecalis:
In the minimal media, Lactobacillus arobinosus and Enterococcus faecalis are able to grow together but not alone.
The synergistic relationship between E. faecalis and L. arobinosus occurs in which E. faecalis require folic acid
在线办理(salfor毕业证书)索尔福德大学毕业证毕业完成信一模一样
学校原件一模一样【微信：741003700 】《(salfor毕业证书)索尔福德大学毕业证》【微信：741003700 】学位证，留信认证（真实可查，永久存档）原件一模一样纸张工艺/offer、雅思、外壳等材料/诚信可靠,可直接看成品样本，帮您解决无法毕业带来的各种难题！外壳，原版制作，诚信可靠，可直接看成品样本。行业标杆！精益求精，诚心合作，真诚制作！多年品质 ,按需精细制作，24小时接单,全套进口原装设备。十五年致力于帮助留学生解决难题，包您满意。
本公司拥有海外各大学样板无数，能完美还原。
1:1完美还原海外各大学毕业材料上的工艺：水印，阴影底纹，钢印LOGO烫金烫银，LOGO烫金烫银复合重叠。文字图案浮雕、激光镭射、紫外荧光、温感、复印防伪等防伪工艺。材料咨询办理、认证咨询办理请加学历顾问Q/微741003700
【主营项目】
一.毕业证【q微741003700】成绩单、使馆认证、教育部认证、雅思托福成绩单、学生卡等！
二.真实使馆公证(即留学回国人员证明,不成功不收费)
三.真实教育部学历学位认证（教育部存档！教育部留服网站永久可查）
四.办理各国各大学文凭(一对一专业服务,可全程监控跟踪进度)
如果您处于以下几种情况：
◇在校期间，因各种原因未能顺利毕业……拿不到官方毕业证【q/微741003700】
◇面对父母的压力，希望尽快拿到；
◇不清楚认证流程以及材料该如何准备；
◇回国时间很长，忘记办理；
◇回国马上就要找工作，办给用人单位看；
◇企事业单位必须要求办理的
◇需要报考公务员、购买免税车、落转户口
◇申请留学生创业基金
留信网认证的作用:
1:该专业认证可证明留学生真实身份
2:同时对留学生所学专业登记给予评定
3:国家专业人才认证中心颁发入库证书
4:这个认证书并且可以归档倒地方
5:凡事获得留信网入网的信息将会逐步更新到个人身份内，将在公安局网内查询个人身份证信息后，同步读取人才网入库信息
6:个人职称评审加20分
7:个人信誉贷款加10分
8:在国家人才网主办的国家网络招聘大会中纳入资料，供国家高端企业选择人才
The debris of the ‘last major merger’ is dynamically young
The Milky Way’s (MW) inner stellar halo contains an [Fe/H]-rich component with highly eccentric orbits, often referred to as the
‘last major merger.’ Hypotheses for the origin of this component include Gaia-Sausage/Enceladus (GSE), where the progenitor
collided with the MW proto-disc 8–11 Gyr ago, and the Virgo Radial Merger (VRM), where the progenitor collided with the
MW disc within the last 3 Gyr. These two scenarios make different predictions about observable structure in local phase space,
because the morphology of debris depends on how long it has had to phase mix. The recently identified phase-space folds in Gaia
DR3 have positive caustic velocities, making them fundamentally different than the phase-mixed chevrons found in simulations
at late times. Roughly 20 per cent of the stars in the prograde local stellar halo are associated with the observed caustics. Based
on a simple phase-mixing model, the observed number of caustics are consistent with a merger that occurred 1–2 Gyr ago.
We also compare the observed phase-space distribution to FIRE-2 Latte simulations of GSE-like mergers, using a quantitative
measurement of phase mixing (2D causticality). The observed local phase-space distribution best matches the simulated data
1–2 Gyr after collision, and certainly not later than 3 Gyr. This is further evidence that the progenitor of the ‘last major merger’
did not collide with the MW proto-disc at early times, as is thought for the GSE, but instead collided with the MW disc within
the last few Gyr, consistent with the body of work surrounding the VRM.
Anti-Universe And Emergent Gravity and the Dark Universe
Recent theoretical progress indicates that spacetime and gravity emerge together from the entanglement structure of an underlying microscopic theory. These ideas are best understood in Anti-de Sitter space, where they rely on the area law for entanglement entropy. The extension to de Sitter space requires taking into account the entropy and temperature associated with the cosmological horizon. Using insights from string theory, black hole physics and quantum information theory we argue that the positive dark energy leads to a thermal volume law contribution to the entropy that overtakes the area law precisely at the cosmological horizon. Due to the competition between area and volume law entanglement the microscopic de Sitter states do not thermalise at sub-Hubble scales: they exhibit memory effects in the form of an entropy displacement caused by matter. The emergent laws of gravity contain an additional ‘dark’ gravitational force describing the ‘elastic’ response due to the entropy displacement. We derive an estimate of the strength of this extra force in terms of the baryonic mass, Newton’s constant and the Hubble acceleration scale a0 = cH0, and provide evidence for the fact that this additional ‘dark gravity force’ explains the observed phenomena in galaxies and clusters currently attributed to dark matter.
Mending Clothing to Support Sustainable Fashion_CIMaR 2024.pdf
Ozturkcan, S., Berndt, A., & Angelakis, A. (2024). Mending clothing to support sustainable fashion. Presented at the 31st Annual Conference by the Consortium for International Marketing Research (CIMaR), 10-13 Jun 2024, University of Gävle, Sweden.
ESA/ACT Science Coffee: Diego Blas - Gravitational wave detection with orbita...
ESA/ACT Science Coffee: Diego Blas - Gravitational wave detection with orbita...Advanced-Concepts-Team
Presentation in the Science Coffee of the Advanced Concepts Team of the European Space Agency on the 07.06.2024.
Speaker: Diego Blas (IFAE/ICREA)
Title: Gravitational wave detection with orbital motion of Moon and artificial
Abstract:
In this talk I will describe some recent ideas to find gravitational waves from supermassive black holes or of primordial origin by studying their secular effect on the orbital motion of the Moon or satellites that are laser ranged.(June 12, 2024) Webinar: Development of PET theranostics targeting the molecu...
(June 12, 2024) Webinar: Development of PET theranostics targeting the molecu...Scintica Instrumentation
Targeting Hsp90 and its pathogen Orthologs with Tethered Inhibitors as a Diagnostic and Therapeutic Strategy for cancer and infectious diseases with Dr. Timothy Haystead.Direct Seeded Rice - Climate Smart Agriculture
Direct Seeded Rice - Climate Smart AgricultureInternational Food Policy Research Institute- South Asia Office
PPT on Direct Seeded Rice presented at the three-day 'Training and Validation Workshop on Modules of Climate Smart Agriculture (CSA) Technologies in South Asia' workshop on April 22, 2024.
快速办理(UAM毕业证书)马德里自治大学毕业证学位证一模一样
学校原件一模一样【微信：741003700 】《(UAM毕业证书)马德里自治大学毕业证学位证》【微信：741003700 】学位证，留信认证（真实可查，永久存档）原件一模一样纸张工艺/offer、雅思、外壳等材料/诚信可靠,可直接看成品样本，帮您解决无法毕业带来的各种难题！外壳，原版制作，诚信可靠，可直接看成品样本。行业标杆！精益求精，诚心合作，真诚制作！多年品质 ,按需精细制作，24小时接单,全套进口原装设备。十五年致力于帮助留学生解决难题，包您满意。
本公司拥有海外各大学样板无数，能完美还原。
1:1完美还原海外各大学毕业材料上的工艺：水印，阴影底纹，钢印LOGO烫金烫银，LOGO烫金烫银复合重叠。文字图案浮雕、激光镭射、紫外荧光、温感、复印防伪等防伪工艺。材料咨询办理、认证咨询办理请加学历顾问Q/微741003700
【主营项目】
一.毕业证【q微741003700】成绩单、使馆认证、教育部认证、雅思托福成绩单、学生卡等！
二.真实使馆公证(即留学回国人员证明,不成功不收费)
三.真实教育部学历学位认证（教育部存档！教育部留服网站永久可查）
四.办理各国各大学文凭(一对一专业服务,可全程监控跟踪进度)
如果您处于以下几种情况：
◇在校期间，因各种原因未能顺利毕业……拿不到官方毕业证【q/微741003700】
◇面对父母的压力，希望尽快拿到；
◇不清楚认证流程以及材料该如何准备；
◇回国时间很长，忘记办理；
◇回国马上就要找工作，办给用人单位看；
◇企事业单位必须要求办理的
◇需要报考公务员、购买免税车、落转户口
◇申请留学生创业基金
留信网认证的作用:
1:该专业认证可证明留学生真实身份
2:同时对留学生所学专业登记给予评定
3:国家专业人才认证中心颁发入库证书
4:这个认证书并且可以归档倒地方
5:凡事获得留信网入网的信息将会逐步更新到个人身份内，将在公安局网内查询个人身份证信息后，同步读取人才网入库信息
6:个人职称评审加20分
7:个人信誉贷款加10分
8:在国家人才网主办的国家网络招聘大会中纳入资料，供国家高端企业选择人才
The binding of cosmological structures by massless topological defects
Assuming spherical symmetry and weak field, it is shown that if one solves the Poisson equation or the Einstein field
equations sourced by a topological defect, i.e. a singularity of a very specific form, the result is a localized gravitational
field capable of driving flat rotation (i.e. Keplerian circular orbits at a constant speed for all radii) of test masses on a thin
spherical shell without any underlying mass. Moreover, a large-scale structure which exploits this solution by assembling
concentrically a number of such topological defects can establish a flat stellar or galactic rotation curve, and can also deflect
light in the same manner as an equipotential (isothermal) sphere. Thus, the need for dark matter or modified gravity theory is
mitigated, at least in part.
fermented food science of sauerkraut.pptx
This ppt contains the production of a fermented food name - sauerkraut
EWOCS-I: The catalog of X-ray sources in Westerlund 1 from the Extended Weste...
Context. With a mass exceeding several 104 M⊙ and a rich and dense population of massive stars, supermassive young star clusters
represent the most massive star-forming environment that is dominated by the feedback from massive stars and gravitational interactions
among stars.
Aims. In this paper we present the Extended Westerlund 1 and 2 Open Clusters Survey (EWOCS) project, which aims to investigate
the influence of the starburst environment on the formation of stars and planets, and on the evolution of both low and high mass stars.
The primary targets of this project are Westerlund 1 and 2, the closest supermassive star clusters to the Sun.
Methods. The project is based primarily on recent observations conducted with the Chandra and JWST observatories. Specifically,
the Chandra survey of Westerlund 1 consists of 36 new ACIS-I observations, nearly co-pointed, for a total exposure time of 1 Msec.
Additionally, we included 8 archival Chandra/ACIS-S observations. This paper presents the resulting catalog of X-ray sources within
and around Westerlund 1. Sources were detected by combining various existing methods, and photon extraction and source validation
were carried out using the ACIS-Extract software.
Results. The EWOCS X-ray catalog comprises 5963 validated sources out of the 9420 initially provided to ACIS-Extract, reaching a
photon flux threshold of approximately 2 × 10−8 photons cm−2
s
−1
. The X-ray sources exhibit a highly concentrated spatial distribution,
with 1075 sources located within the central 1 arcmin. We have successfully detected X-ray emissions from 126 out of the 166 known
massive stars of the cluster, and we have collected over 71 000 photons from the magnetar CXO J164710.20-455217.
Methods of grain storage Structures in India.pdf
•Post-harvestlossesaccountforabout10%oftotalfoodgrainsduetounscientificstorage,insects,rodents,micro-organismsetc.,
•Totalfoodgrainproductioninindiais311milliontonnesandstorageis145mt.InIndia,annualstoragelosseshavebeenestimated14mtworthofRs.7,000croreinwhichinsectsaloneaccountfornearlyRs.1,300crores.
•InIndiaoutofthetotalproduction,about30%ismarketablesurplus
•Remaining70%isretainedandstoredbyfarmersforconsumption,seed,feed.Hence,growerneedstoragefacilitytoholdaportionofproducetosellwhenthemarketingpriceisfavourable
•TradersandCo-operativesatmarketcentresneedstoragestructurestoholdgrainswhenthetransportfacilityisinadequate
Describing and Interpreting an Immersive Learning Case with the Immersion Cub...
Current descriptions of immersive learning cases are often difficult or impossible to compare. This is due to a myriad of different options on what details to include, which aspects are relevant, and on the descriptive approaches employed. Also, these aspects often combine very specific details with more general guidelines or indicate intents and rationales without clarifying their implementation. In this paper we provide a method to describe immersive learning cases that is structured to enable comparisons, yet flexible enough to allow researchers and practitioners to decide which aspects to include. This method leverages a taxonomy that classifies educational aspects at three levels (uses, practices, and strategies) and then utilizes two frameworks, the Immersive Learning Brain and the Immersion Cube, to enable a structured description and interpretation of immersive learning cases. The method is then demonstrated on a published immersive learning case on training for wind turbine maintenance using virtual reality. Applying the method results in a structured artifact, the Immersive Learning Case Sheet, that tags the case with its proximal uses, practices, and strategies, and refines the free text case description to ensure that matching details are included. This contribution is thus a case description method in support of future comparative research of immersive learning cases. We then discuss how the resulting description and interpretation can be leveraged to change immersion learning cases, by enriching them (considering low-effort changes or additions) or innovating (exploring more challenging avenues of transformation). The method holds significant promise to support better-grounded research in immersive learning.
Recently uploaded (20)
MICROBIAL INTERACTION PPT/ MICROBIAL INTERACTION AND THEIR TYPES // PLANT MIC...
MICROBIAL INTERACTION PPT/ MICROBIAL INTERACTION AND THEIR TYPES // PLANT MIC...
The debris of the ‘last major merger’ is dynamically young
The debris of the ‘last major merger’ is dynamically young
Anti-Universe And Emergent Gravity and the Dark Universe
Anti-Universe And Emergent Gravity and the Dark Universe
GBSN - Biochemistry (Unit 6) Chemistry of Proteins
GBSN - Biochemistry (Unit 6) Chemistry of Proteins
Mending Clothing to Support Sustainable Fashion_CIMaR 2024.pdf
Mending Clothing to Support Sustainable Fashion_CIMaR 2024.pdf
Tissue fluids_etiology_volume regulation_pressure.pptx
Tissue fluids_etiology_volume regulation_pressure.pptx
ESA/ACT Science Coffee: Diego Blas - Gravitational wave detection with orbita...
ESA/ACT Science Coffee: Diego Blas - Gravitational wave detection with orbita...
(June 12, 2024) Webinar: Development of PET theranostics targeting the molecu...
(June 12, 2024) Webinar: Development of PET theranostics targeting the molecu...
The binding of cosmological structures by massless topological defects
The binding of cosmological structures by massless topological defects
Microbiology of Central Nervous System INFECTIONS.pdf
Microbiology of Central Nervous System INFECTIONS.pdf
EWOCS-I: The catalog of X-ray sources in Westerlund 1 from the Extended Weste...
EWOCS-I: The catalog of X-ray sources in Westerlund 1 from the Extended Weste...
Describing and Interpreting an Immersive Learning Case with the Immersion Cub...
Describing and Interpreting an Immersive Learning Case with the Immersion Cub...
Alzheimer's Animal Model
- 1. 1/5/2015 Biomedical Research Models, Inc. Contract Discovery and Preclinical Research Alzheimer’s Disease
- 2. 1/5/2015 Clinical Symptoms of AD • Memory loss that disrupts daily life • Changes in planning of solving problems • Difficulty completing familiar tasks at home, at work or at leisure • Confusion with time or place • Trouble understanding visual images and spatial relationships • New problems with words in speaking or writing • Misplacing things and losing the ability to retrace steps • Decreased or poor judgment • Withdrawal from work or social activities • Changes in mood and personality
- 3. 1/5/2015 Risk Factors of AD • Age • Genetics • Insulin resistance • Hyperglycemia • Inflammation • Oxidative stress
- 4. 1/5/2015 7 Stages of Alzheimer’s Disease 7 Stages of AD • 1 – no impairment • 2 – very mild decline • 3 – mild decline • 4 – moderate decline (mild to early stage) • 5 – moderately server decline (moderate to mid- stage) • 6 – sever decline (moderately severe to mid- stage) • 7 – very severe decline (severe or late state)
- 5. 1/5/2015 Comparison between BB/Wor- and BBZDR/Wor-Diabetic Rats 1. Neuronal loss 2. Neuronal apoptosis 3. Alterations of various factors mediating apoptotic activity: - Apoptosis-regulating proteins - Perturbation of IGF system - Activation of Fas/NGF-R.p75 - Oxidative stress: PARP, 8-OHdG - Caspase activation
- 6. 1/5/2015 CA1 CA2 CA3 CA4 DF Sub Neuronal densities in type 1 vs. type 2 diabetic BB/Wor ratsNeuronaldensity(numbers/mm2) 0 500 1000 1500 2000 2500 3000 3500 CA1 CA2 CA3 CA4 *** * * † * p < 0.05, *** p < 0.001 vs. control, † p < 0.05 vs. BB/Wor Control (n=4) BBZDR/Wor (n=4) BB/Wor (n=4)
- 7. 1/5/2015 a). Active caspase-3 * 0 1.0 2.0 3.0 Control BB/Wor BBZDR 15 kD 22 kD -17 kD b). Caspase 12 0 1.0 2.0 3.0 4.0 * † Control BB/Wor BBZDR 51 kD 62 kD -55 kD Relativedensity(Arbitralunit) Relativedensity(Arbitralunit) * p < 0.05 vs. control; † p < 0.05 vs. BB/Wor Expression of caspases in type 1 vs. type 2 diabetic BB/Wor rats
- 8. 1/5/2015 * p < 0.05, ** p < 0.01 vs. control. † p < 0.05 vs. BB/Wor Bax Control BB/Wor BBZDR /Wor Bcl-xL Control BB/Wor BBZDR/Wor 0 1.0 2.0 3.0 ** † 0 0.5 1.0 1.5 Relativedensity(Arbitralunit) Apoptosis- regulating proteins in type 1 vs. type 2 diabetic BB/Wor rats (hippocampus, 8 months)
- 9. 1/5/2015 Splicing of the transmembranous APP-molecule APP Cell-membrane -secretase -secretase I-40 AS (vessels) I-42 AS (neurons)
- 10. 1/5/2015 APP Frontal Cortex Control BB/W BB/ZDR Cont BB/W BB/Z 0.0 1.0 2.0 3.0 ** ** ** p < 0.005 vs. control
- 11. 1/5/2015 β – Secretase Frontal Cortex Control BB/W BB/ZDR Cont BB/W BB/Z 0.0 1.0 2.0 * ** * p < 0.05, ** p < 0.005 vs. control
- 12. 1/5/2015 Control BBW BBZ Aβ 1-42 Frontal Cortex Cont BB/W BB/Z * ** * 0.0 2.0 3.0 1.0 2.0 * p < 0.05, ** p < 0.005 vs. control
- 13. 1/5/2015 Formation of Paired Helical Filaments (NFT) β-amyloid Adap78 Calcineurin Hyperphosphorylated Tau Caspase 3 Spliced Tau ; β Enmark and Davis, 2002 APOPTOSIS Apoptosis inducing elements Cell death
- 14. 1/5/2015 References • Li ZG., Zhang W., Sima AA. Alzheimer-like changes in rat models of spontaneous diabetes. Diabetes 2007 Oct;56(10):2650. • Sima AA. Encephalopathies: the emerging diabetic complications. Acta Diabetologica August 2010. 14